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INTRODUCTION
The deterioration of cognitive functioning is a crucial fea-
ture of schizophrenia patients, and many of the meta-analy-
ses have suggested a wide-range of cognitive impairments
in schizophrenia patients (1).
However, there are inconsistent results regarding the cogni-
tive architecture in schizophrenia. One of the reasons is that
the human cognitive system is very complex. Although the-
oretical considerations, studies of brain localization, and devel-
opments in neuroscience are continuously made, the distinc-
tive components of the cognitive system and their relations
with one another are difficult to confirm. Second, it is not
guarantee that neurocognitive tests assess only the specific
cognitive domains or brain regions that they were designed
to test. Since the performances of individual tests are influ-
enced by a number of cognitive abilities, it is not uncommon
that a test used in assessing a specific cognitive domain in
one study is assigned to a different domain in another study
(2). Lastly, the most important reason is that it is difficult to
compare the results of previous studies because of the differ-
ences in their materials and methods. Specially, wide varia-
tions in the type of tests and the total number of tests admin-
istered constitute an important potential obstacle in making
parallel comparisons, because the results of the factor analy-
sis may have substantial differences due to the composition
of variables (3). Recent factor analysis studies have yielded
inconsistent factor solutions, in which the number of factors
identified range from 2 to 14 (4).
Despite these limitations, identifying the cognitive domains
is a crucial step in the research of schizophrenia. These domains
have been applied in making a diagnosis, evaluating a course
of illness and used as an endophenotype in genetic studies.
Therefore, various neurocognitive batteries, including diverse
domains, have been developed (5, 6). 
One of the promising neurocognitive batteries is the MCCB
(MATRICS Consensus Cognitive Battery). The National Insti-
tute of Mental Health (NIMH) of the United States devel-
oped the Measurement and Treatment Research to Improve
Cognition in Schizophrenia (MATRICS) initiative in order
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Factor Structure of the Neurocognitive Tests: An Application of the
Confirmative Factor Analysis in Stabilized Schizophrenia Patients
The purpose of the present study was to identify the factor structure of neurocogni-
tive tests used on schizophrenia patients by using the confirmative factor analysis,
and to assess the factor score differences of schizophrenia patients and healthy con-
trols. Comprehensive neurocognitive tests were administered to stabilized schizophre-
nia patients (N=114) and healthy controls (N=120). In the results of factor analyses
on patients, the multifactorial-6-factor model, which included the speed of process-
ing, working memory, verbal learning and memory, visual learning and memory, atten-
tion/vigilance, and reasoning/problem solving as suggested by the Measurement
and Treatment Research to Improve Cognition in Schizophrenia (MATRICS), showed
the better goodness of fit than any of the other models tested. And assessing the
group differences of factor scores, we found the patients performed worse than the
controls in all factors, but the result showed meaningful variations of impairments
across the cognitive factors. Our study identifies the six major domains with multi-
factorial structure of cognitive abilities in schizophrenia patients and confirms the
distinctive impairment patterns of each cognitive domain. These results may have
utility in better understanding the pathology of schizophrenia as well as in genetic
studies. 
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to provide a consensus of the crucial cognitive domains of
schizophrenia (7). Based on the extensive empirical evidence,
literature, and discussions by experts, the MATRICS Neu-
rocognition Committee suggests seven cognitive factors of
schizophrenia and the tests that are required in order to mea-
sure each of these domains (8).
However, another controversy exists regarding the structure
of cognition in schizophrenia. Most factor analyses research
treat cognitive factors in schizophrenia as ‘separable’ and ‘dis-
crete’. However, some studies emphasized that the general
cognitive ability is defined as the ‘g’ factor or have suggest-
ed that some of the sub-domains do not need to be divided
(2, 9). Dickinson et al. (9) has found that cognitive ability
appears to be more unitary in schizophrenia than in healthy
subjects. They suggested that the hierarchical model (has a
higher order latent factor, representing general cognitive abili-
ty) is more appropriate than the multifactorial model (each
of the latent factors cause performance on the individual tests)
to test the cognitive structure of schizophrenia.
The goal of the present study was to examine the factor
structure of neurocognitive tests in schizophrenia patient using
confirmative factor analysis (CFA). First, we composed the
neurocognitive battery including factors suggested by MA-
TRICS and conducted to examine that MATRICS model
fits to the empirical data. Second, we analyzed which of the
multifactorial model or the hierarchical model is better appro-
priate for understanding schizophrenia cognitive structure.
Additionally, we administered the same battery to healthy
control subjects and assessed the factor scores differences bet-
ween the groups to validate the distinctive impairments pat-
terns and discuss the utility of factor scores.
MATERIALS AND METHODS
Participants 
The study participants were comprised of 114 schizophrenia
patients and 120 healthy controls. The patients were recruit-
ed from the outpatient clinics of the Samsung Medical Cen-
ter and the Yong-In Mental Hospital. Diagnosis of patients
was confirmed by the consensus among the researchers of this
study using the Diagnostic and Statistical Manual of Men-
tal Disorder-Fourth edition (DSM-IV) criteria based on obser-
vation, case notes, and the Korean Version of the Diagnostic
Interview for Genetic Studies (DIGS-K) (10). Only clinical
stabilized patients were included in this research in order to
reduce confounding factors such as the severity of symptoms.
All patients had a 1) current Clinical Global Impression (CGI)
score below 3, 2) no psychotic symptom exacerbation, and
3) no changes in medication for at least three months prior
to the time of the assessment. We excluded patients with a
concurrent axis I diagnosis of DSM-IV, which is a current or
past medical disease that is likely to have a significant effect
on the central nervous system. Controls were free of all Axis I
psychiatric disorders and familiar loading to second-degree
relatives, and did not have a medical disorder that may alter
cognitive functioning. Written informed consent was obtain-
ed from all of the subjects after a complete explanation of the
study was provided. The study was approved by the institu-
tional review boards of the Samsung Medical Center and the
Yong-In Mental Hospital. Demographic and clinical charac-
teristics of the participants are shown in Table 1. Differences
in age, education, and the premorbid intellectual functioning,
which was estimated from the Korean version of the Wech-
sler Adult Intelligence Scale (K-WAIS) vocabulary score, were
considered in the group comparison analyses. This study was
approved by the Institutional Review Board (2004-09-36).
Neurocognitive assessment 
The neurocognitive battery was composed of comprehen-
sive tests that correspond to the six cognitive domains of the
MATRICS, which were the speed of processing, working mem-
ory, verbal learning and memory, visual learning and mem-
ory, attention/vigilance, and reasoning/problem solving. Social
cognition, which is the 7th domain of the MATRICS, was
not included since the appropriate tools were not validated
Parameters
Schizophrenia
(n=114)
Healthy 
control
(n=120)
Test
analysis
P
value
Male Sex: N (%) 58 (50.9) 59 (49.2) c2=0.016 0.90
Age:mean 30.6  27.1  t=-4.63 0.00
(SD, range) (7.1, 18-48) (4.4, 20-43)
Education years: mean 14.1 15.6 t=6.08 0.00
(SD, range) (2.1, 8-18) (1.5, 12-18)
K-WAIS: vocabulary: 10.9 12.6 t=5.50 0.00
mean (SD, range) (2.5, 3-15) (2.4, 4-17)
Age of onset: mean  23.3
(SD, range) (6.0, 12-42)
Duration of illness: yr  7.1
mean (SD, range)  (5.9, 0-26)
Number of hospitalization: 2.3
mean (SD, range) (2.4, 0-13)
CGI score: mean  2.0
(SD, range)  (0.6, 1-3)
First medication: N (%)
Risperidone 34 (29.8)
Clozapine 22 (19.3)
Olanzapine 15 (13.2)
Amisulpride 12 (10.5)
Aripiprazole 9 (7.9)
Haloperidol 8 (7.0)
Ziprasidone 7 (6.1)
Others 7 (6.1)
Table 1. Demographic and clinical characteristics of the partic-
ipants 
K-WAIS, Korean version of the Wechsler Adult Intelligence Scale; CGI,
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in Koreans. According to the psychometric characteristic cri-
teria suggested by the MATRICS (8) and previous analysis
of multicollinearity (11), a total of 19 variables were employed
for the statistical analyses (Table 2). 
Competing models
Fig. 1 shows the 6-factor model and the five nested mod-
els. The 1-factor model evaluated the general cognitive abil-
ity of all the tests (12). The 2-factor model included both
the verbal and the visual ability based on Wechsler’s origi-
nal concepts (13). The 3-factor model was composed of the
verbal ability, visual processing, and the speed of processing
that is consistent with the factor analyses from recent ver-
sions of the Wechsler intelligence scales (14, 15). The 4-fac-
tor model does not have exactly the same prior theories, but
is based on the studies that have separated the attention/
working memory from the verbal ability in the intelligence
tests of both adults and children (16, 17). The 5-factor model
was predicted by the CFA study of Gladsjo et al. (18) with
the exception of the ‘verbal crystallized’ factor. Finally, the
6-factor model is our hypothetical model that was recom-
mended by MATRICS.
The 4-factor, 5-factor, and 6-factor models were also divid-
ed into two competing models that have either a multifacto-
Domains Tests
Speed of processing K-WAIS digit symbol*
Trail-Making-Test A: time
Trail-Making-Test B: time
Letter fluency (ㄱ,ㅅ,ㅇ)
Category fluency
Working memory K-WAIS digit span-backward
1-back test: correct %
2-back test: correct %
K-WAIS arithmetic*
Verbal learning and memory K-AVLT learning: 1-5 trials mean*
K-AVLT delayed recall*
K-AVLT recognition*
Visual learnig and memory K-CFT copy*
K-CFT delayed recall*
Attention/vigilance DS-CPT: sensitivity d’ value
Span: 3 letter correct %
Span: 12 letter correct %
Reasoning/problem solving K-WAIS picture arrangement*
K-WAIS block design*
Table 2. Tests grouped by cognitive domain
*using scaled scores in analyses.
K-WAIS, Korean version of the Wechsler Adult Intelligence Scale; K-
AVLT, Korean version of Auditory Verbal Learning Test; K-CFT, Korean
version of Complex Figure Test; DS-CPT, Degraded Stimulus-Continu-
ous Performance Test. 
6-factor
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memory
Attention/
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Verbal learning
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Visual learning
& memory
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/problem
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Fig. 1. 6-factor models recommend by MATRICS and alternative models.
Fig. 2. Representation of the hierarchical and multifactorial models.
Hierarchical model Multifactorial modelrial structure or a hierarchical structure (Fig. 2). The multi-
factorial model has separate latent cognitive factors that cause
performance on the individual tests, and these latent factors
can be intercorrelated. The hierarchical model has a single
second order latent factor which causes performance in dif-
ferent cognitive domains (9).
Statistical analyses
The structure of the neurocognitive tests was determined
via the CFA. Only data from the patients were included in
the CFA. Prior to analyses, the data was evaluated for multi-
variate nonnormality (19). The multivariate kurtosis was sig-
nificantly high (12.918), and because of this the Maximum
likelihood Estimation (MLE) extraction with Bollen-Stine
bootstrapping (20) was used in order to meet the multivari-
ate normality assumption of MLE. Error variables that shared
a common method effect were allowed to correlate to improve
the fitting of the model (18). 
According to the CFA-derived best fit model structure,
the factor scores of the patients and the healthy controls were
compared using the MANCOVA analysis while controlling
for age, education and premorbid intellectual functioning.
Factor scores were determined by averaging the standardized
Z scores by using the means and standard deviations of the
healthy control group (21, 22). The analyses in this study were
conducted using the SPSS 15.0 and the AMOS 7.0 software.
RESULTS
Confirmatory factor analyses of the schizophrenia patients
We examined the goodness of fit and the parameters by
adding four pairs of correlated errors (Tail-Making-Test A
and Tail-Making-Test B, letter fluency and category fluency,
1-back test and 2-back test, and 3 letter Span and 12 letter
Span) based on prior studies and the modification index used
to control for the method effect. The fit indices for the test-
ed models are shown in Table 3. The multifactorial-6-factor
model had the best fit compared to any of the other competing
models. The c2/df and the Root Mean Square Error of Approx-
imation (RMSEA) for the multifactorial-6-factor model met
the established guideline (23) for adequate fit (c2/df=1.57,
RMSEA=0.071). Other fit statistics of all models failed to
meet the criteria standards, but the multifactorial-6-factor
model was relatively appropriate (CFI=0.889, GFI=0.843,
NFI=0.755, TLI=0.857). 
Table 4 shows the factor loadings of the multifactorial-6-
factor model. The factor loading of K-WAIS digit span-back-
ward on ‘Working memory’ is relative low, but the loadings
of all the observed variances of the multifactorial-6-factor
model are significant (standardized regression weight=0.274-
0.986). 
Differences of factor scores between schizophrenia
patients and control subjects
In Table 5, the mean z-scores and the standard deviations
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Tests SP WM VM VSM AV RP
K-WAIS digit symbol 0.625
Trail-Making-Test A  0.456
Trail-Making-Test B  0.505
Letter fluency 0.488
Category fluency 0.412
K-WAIS digit span- 0.275
backward
1-back test  0.529
2-back test 0.473
K-WAIS arithmetic 0.570
K-AVLT learning  0.904
K-AVLT delayed recall 0.850
K-AVLT recognition 0.697
K-CFT copy 0.472
K-CFT delayed recall 0.886
DS-CPT 0.678
3 letter Span 0.485
12 letter Span  0.673
K-WAIS picture  0.502
arrangement
K-WAIS block design 0.640
Table 4. Factor loading for the multifactorial-6-factor model 
SP, speed of processing; WM, working memory; VM, verbal learning
&memory; VSM, visual learning&memory; AV, attention/vigilance; RP,
reasoning/problem solving; K-WAIS, Korean version of the Wechsler
Adult Intelligence Scale; K-AVLT, Korean version of Auditory Verbal
Learning Test; K-CFT, Korean version of Complex Figure Test; DS-CPT,
Degraded Stimulus-Continuous Performance Test. 
Model RMSEA GFI NFI TLI CFI c2/df Df c2
1 factor 386.74 148 2.61 0.649 0.709 0.546 0.594 0.119
2 factor 366.35 147 2.50 0.677 0.708 0.570 0.625 0.115
3 factor 352.75 145 2.43 0.695 0.719 0.586 0.640 0.113
4 factor
Multifactorial 240.68 142 1.70 0.855 0.823 0.717 0.825 0.078
Hierarchical 249.38 144 1.73 0.845 0.809 0.707 0.816 0.080
5 factor
multifactorial 220.58 138 1.60 0.879 0.835 0.741 0.850 0.073
hierarchical 234.69 143 1.64 0.865 0.822 0.724 0.839 0.075
6 factor
multifactorial 208.78 133 1.57 0.889 0.843 0.755 0.857 0.071
hierarchical 226.11 142 1.59 0.876 0.828 0.734 0.851 0.072
Table 3. Goodness-of-fit indices of overall models 
An acceptable model fit was defined by the following criteria: c2/df (1-2),
GFI (≥0.90), NFI (≥0.90 ), CFI (≥0.90), TLI (≥0.90), RMSEA (≥0.08).
CFI, comparative fit index; GFI, goodness of fit index; NFI, normed fit
index; TLI, Tucker-Lewis index; RMSEA, root mean square error of ap-
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for the cognitive domains were compared. All of the factor
scores were significantly lower in the patient group (F [6,211]=
23.698, P<0.001, Wilk’s Lamda=0.597; partial eta square=
0.403). More pronouncing deficits were observed in ‘Process-
ing of information’ (mean Z score=-1.96) and ‘Verbal learning
and memory’ (mean Z score=-1.28). Patients showed moder-
ate impairments in ‘Working memory’ (mean Z score=-1.17)
and ‘Attention/Vigilance’ (mean Z score=-1.15). ‘Visual learn-
ing and memory’ (mean Z score=-0.69) and ‘Reasoning and
problem solving’ (mean Z score=-0.79) were relatively mild-
ly impaired. 
DISCUSSION
The purpose of the present study was to assess the factor
structure of neurocognitive tests used on schizophrenia pati-
ents by using the confirmatory factor analysis. And we com-
pared the differences of the factor scores between schizophrenic
patients and control subjects.
First, our results confirmed that the 6-factor model that
was proposed by MATRICS is more appropriate than any of
the competing models that were tested. Although this result
is difficult to compare to the results of previous factor analytic
studies directly, all six domains of this model have been repli-
cated as major cognitive functions of schizophrenia. ‘Speed
of processing’ was composed of tests that were shown to dis-
tinguish impairments in schizophrenia patients and their fami-
ly. The construction validity and neurological mechanism of
this is difficult to explain, but all of the tests that involve both
perceptual and motor components and the many factor anal-
ysis studies support that this is one of the most basic domains
(24). ‘Working memory’ was defined as the capacity to simul-
taneously store, process and manipulate information, and de-
ficits of this in schizophrenia patients are consistently demon-
strated across a diverse range of tasks. In our results, the fac-
tor loading of K-WAIS digit span-backward on this dimen-
sion was low. It is a reason that this task also thought of as a
measure of ‘Attention/Vigilance’ in other studies, that is, the
validity of this task on ‘Working memory’ is relative lower,
so less loads on this dimension. ‘Reasoning and problem solv-
ing’ are the skills in planning and decision making, and mean-
ingfully relate to the real world functioning of schizophre-
nia patients. ‘Reasoning and problem solving’ and ‘Working
memory’ can be referred together as ‘executive functioning’.
However, using ‘executive functioning’ as a unitary cognitive
operation has been criticized, because it may require a higher
ability level to connect and control the information between
subsystems (2). This is why MATRICS tried to divide ‘exec-
utive functioning’ into two domains and our study supports
this idea. An abundant number of studies have revealed both
stable and wide memory deficits in schizophrenia patients.
Memory functioning can be divided in to a lot of sub domains,
most especially as ‘Verbal memory’ and ‘Visual memory’, which
has been conceptualized as separable areas and replicated to
have a respective course of impairments. The ‘Attention/Vigi-
lance’ is described in the early clinical accounts of schizophre-
nia, and is one of the most frequently studied cognitive deficits
and show relationships to everyday functioning (3). 
Second, we found that the multifactorial model provided
a better fit than the hierarchical model. Our research con-
firmed the assumption that cognitive dimensions are ‘inde-
pendent’. Recent studies that used novel data-mining meth-
ods with no prior assumptions also supported ‘separable’ fac-
tors (25). The multifactorial structure was verified by the dis-
tinct relationships between the factors and the clinical or func-
tional capacity variables. Longitudinal studies have indenti-
fied that the response to the course and type of anti-psychotic
treatment for each type of cognitive domain are diverse (26). 
Additionally, we can also validate the multifactorial model
by identifying the differences in impairments between the
cognitive factors. Schizophrenia patients performed worse
than the controls in all of the domains tested, but the result
showed meaningful variations of deficits. Similar to a num-
ber of previous studies, our results showed that the most severe
impairments were found in the ‘Speed of processing’ and the
‘Verbal memory’. These impairments are either stable or pro-
gressively deteriorating (27, 28). Deficits of the ‘Working
memory’ and the ‘Attention/Vigilance’ were moderate since
the early stages of the illness, and the ‘Visual memory’ is rela-
tively preserved (29). In our results, the impairments of the
‘Reasoning/problem solving’ are relatively mild, and this find-
Age, education, premorbid intellectuan functioning as covariate. 
P<0.008 to set the critical alpha level after Bonferroni correction divied by the number of domains (0.05/6).
Schizophrenia
Cognitive domains
Mean SD
Healthy control
Mean SD
F
P
value
Partial eta
square
Speed of processing -1.96 1.38 -0.02 0.62 77.70 0.000 0.265
Working memory -1.17 0.66 0.01 0.72 65.51 0.000 0.233
Verbal learning & memory -1.28 1.32 -0.03 0.89 60.70 0.000 0.219
Visual learning & memory -0.69 1.03 -0.02 0.85 21.16 0.000 0.089
Attention/vigilance -1.15 1.46 0.00 0.69 19.54 0.000 0.083
Reasoning/problem solving -0.79 0.94 0.02 0.85 16.26 0.000 0.070
Table 5. Comparison of z-scores on cognitive domains between patients and healthy controls Neurocognitive Tests in Schizophrenia 281
ing is inconsistent with the results of some previous studies.
It may be a reason that some previous studies put ‘reasoning/
problem solving’ and ‘executive functioning’ in the same cate-
gory, so used more complex level tests diverse and high order
cognitive abilities needed.
Reducing the variables in a large cognitive battery to major
cognitive abilities may reflect latent traits and may result in
having better psychometric properties (4). Clarifying the fea-
tures of cognition by the progress of illness may have utility
in reducing the type 1 or 2 error in making a diagnosis and
would result in a better understanding of the pathology of
schizophrenia. This also has more implications on genetic
studies since specific cognitive deficits can be associated with
specific genes, brain function or pharmacological mechanism
more definitively. 
Our study has several limitations. First, the multifactori-
al-6-factor model did not fulfill all of the goodness-of-fit cri-
teria. This may have been attributed to an insufficient sam-
ple size to case per variable ratio for the factor analysis. Anoth-
er reason may be due to the differences in the tests and group-
ing measures that were used in our batteries than what was
recommended by the MATRICS. This limitation is not un-
common in factor analysis when using a large number of vari-
ables that are derived from the multiplicity tests. Second, the
social cognition was not included even though it was men-
tioned as the most recent domain of interest by the MAT-
RICS. The validation and development of tests to measure
social cognition in Korean needs to be completed before it
can be studied in a Korean population. Actually, other new
cognitive domains and their interactions need to also be stud-
ied. Recently, the CNTRICS (Cognitive Neuroscience Treat-
ment Research to Improve Cognition in Schizophrenia) pro-
ject was initiated to identify a set of cognitive systems and
to develop optimized measurements based on the cognitive
neuroscience approach (30). It is important to recognize that
the results of our study are tentative conclusions of the cog-
nitive architecture of schizophrenia in order to design and
interpret cognitive test batteries. Defining new cognitive
domains, elaborating tests, and identifying the multi-level
and dynamic interactions of all known domains must be fur-
ther researched.
In summary, using the confirmatory factor analysis of neu-
rocognitive tests on schizophrenia patients, our study iden-
tifies that the multifactorial-6-model suggested by MATRICS
based on the prior studies and theoretical considerations is
best fit the data. Also we confirm the distinctive deficits pat-
terns across the cognitive domains by assessing the differences
of factor scores between schizophrenia patients and healthy
controls.
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